Suppr超能文献

玻璃体内注射更昔洛韦治疗艾滋病患者巨细胞病毒性视网膜炎

[Intravitreal ganciclovir in cytomegalovirus retinitis in AIDS].

作者信息

Olea J L, Salvat M, Mateos J M, Vila J, Villalonga C, Riera M

机构信息

Servicio de Oftalmología, Hospital Son Dureta, Palma de Mallorca.

出版信息

Rev Clin Esp. 1996 Apr;196(4):208-12.

PMID:8701057
Abstract

A retrospective study was made of 26 patients with AIDS who initially presented with retinitis as the only clinical manifestation of cytomegalovirus infection (39 eyes). Sixty-five induction or re-induction therapeutic courses were administered with intravitreal ganciclovir. The efficiency rate of therapy was 93.8%. Thirty-eight maintenance therapeutic courses (200 micrograms/week) were evaluated. The non-compliance rate was 23%. Bilateral retinitis occurred in 44.4% of cases. The systemic administration of therapy had to be substituted for the intravitreal administration in 32% of patients during the clinical course of their conditions. The mean survival rate was 9.5 months. Both retinal detachment and vitreal hemorrhage occurred in 5% of patients. When retinitis is the first clinical manifestation of cytomegalovirus infection, therapy with intravitreal ganciclovir is efficacious to inactivate lesions. Although bilateral retinitis and extraocular dissemination are common, the mean survival rate is high.

摘要

对26例最初以视网膜炎作为巨细胞病毒感染唯一临床表现的艾滋病患者(39只眼)进行了一项回顾性研究。采用玻璃体内注射更昔洛韦进行了65个诱导或再诱导治疗疗程。治疗有效率为93.8%。评估了38个维持治疗疗程(200微克/周)。不依从率为23%。44.4%的病例发生双侧视网膜炎。在32%的患者病程中,不得不将全身治疗替代为玻璃体内治疗。平均生存率为9.5个月。5%的患者发生视网膜脱离和玻璃体积血。当视网膜炎是巨细胞病毒感染的首发临床表现时,玻璃体内注射更昔洛韦治疗可有效使病变失活。虽然双侧视网膜炎和眼外播散很常见,但平均生存率较高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验